- $22.63bn
- $25.76bn
- $4.96bn
- 87
- 22
- 82
- 68
R2019 March 31st | R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,782 | 3,031 | 3,108 | 4,585 | 4,958 |
Cost of Revenue | |||||
Gross Profit | 1,175 | 1,320 | 1,343 | 2,016 | 2,160 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,371 | 2,494 | 2,559 | 4,159 | 4,690 |
Operating Profit | 411 | 537 | 548 | 426 | 268 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 369 | 499 | 518 | 315 | 157 |
Provision for Income Taxes | |||||
Net Income After Taxes | 305 | 408 | 397 | 243 | 106 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 304 | 408 | 397 | 244 | 107 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 304 | 408 | 397 | 244 | 107 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.56 | 4.93 | 5.18 | 4.73 | 4.61 |
Dividends per Share |